English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 76 | Tables: 76 | Pharma & Healthcare
The global market for Whole Exome Sequencing was valued at US$ 367 million in the year 2024 and is projected to reach a revised size of US$ 773 million by 2031, growing at a CAGR of 11.4% during the forecast period.
Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Whole Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Exome Sequencing.
The Whole Exome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Whole Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Exome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Segment by Type
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Segment by Application
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Exome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Exome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Agilent HaloPlex
1.2.3 Agilent SureSelect
1.2.4 Agilent SureSelect QXT
1.2.5 Illumina TruSeq Exome
1.2.6 Roche Nimblegen SeqCap
1.2.7 MYcroarray MYbaits
1.3 Market by Application
1.3.1 Global Whole Exome Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Correlation Research of Normal Human
1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
1.3.4 The Research of Complex Diseases
1.3.5 Mouse Exome Sequencing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Exome Sequencing Market Perspective (2020-2031)
2.2 Global Whole Exome Sequencing Growth Trends by Region
2.2.1 Global Whole Exome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Whole Exome Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Whole Exome Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Whole Exome Sequencing Market Dynamics
2.3.1 Whole Exome Sequencing Industry Trends
2.3.2 Whole Exome Sequencing Market Drivers
2.3.3 Whole Exome Sequencing Market Challenges
2.3.4 Whole Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Exome Sequencing Players by Revenue (2020-2025)
3.1.2 Global Whole Exome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Whole Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Whole Exome Sequencing Revenue
3.4 Global Whole Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Exome Sequencing Revenue in 2024
3.5 Global Key Players of Whole Exome Sequencing Head office and Area Served
3.6 Global Key Players of Whole Exome Sequencing, Product and Application
3.7 Global Key Players of Whole Exome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Exome Sequencing Breakdown Data by Type
4.1 Global Whole Exome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Whole Exome Sequencing Forecasted Market Size by Type (2026-2031)
5 Whole Exome Sequencing Breakdown Data by Application
5.1 Global Whole Exome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Whole Exome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Whole Exome Sequencing Market Size (2020-2031)
6.2 North America Whole Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Whole Exome Sequencing Market Size by Country (2020-2025)
6.4 North America Whole Exome Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Exome Sequencing Market Size (2020-2031)
7.2 Europe Whole Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Whole Exome Sequencing Market Size by Country (2020-2025)
7.4 Europe Whole Exome Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Exome Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Whole Exome Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Whole Exome Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Whole Exome Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Exome Sequencing Market Size (2020-2031)
9.2 Latin America Whole Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Whole Exome Sequencing Market Size by Country (2020-2025)
9.4 Latin America Whole Exome Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Exome Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Whole Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Whole Exome Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Whole Exome Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Whole Exome Sequencing Introduction
11.1.4 Illumina Revenue in Whole Exome Sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Whole Exome Sequencing Introduction
11.2.4 Thermo Fisher Revenue in Whole Exome Sequencing Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Whole Exome Sequencing Introduction
11.3.4 Roche Revenue in Whole Exome Sequencing Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Angilent
11.4.1 Angilent Company Details
11.4.2 Angilent Business Overview
11.4.3 Angilent Whole Exome Sequencing Introduction
11.4.4 Angilent Revenue in Whole Exome Sequencing Business (2020-2025)
11.4.5 Angilent Recent Development
11.5 Eurofins
11.5.1 Eurofins Company Details
11.5.2 Eurofins Business Overview
11.5.3 Eurofins Whole Exome Sequencing Introduction
11.5.4 Eurofins Revenue in Whole Exome Sequencing Business (2020-2025)
11.5.5 Eurofins Recent Development
11.6 Sengenics
11.6.1 Sengenics Company Details
11.6.2 Sengenics Business Overview
11.6.3 Sengenics Whole Exome Sequencing Introduction
11.6.4 Sengenics Revenue in Whole Exome Sequencing Business (2020-2025)
11.6.5 Sengenics Recent Development
11.7 Ambry
11.7.1 Ambry Company Details
11.7.2 Ambry Business Overview
11.7.3 Ambry Whole Exome Sequencing Introduction
11.7.4 Ambry Revenue in Whole Exome Sequencing Business (2020-2025)
11.7.5 Ambry Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Details
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Whole Exome Sequencing Introduction
11.8.4 Macrogen Revenue in Whole Exome Sequencing Business (2020-2025)
11.8.5 Macrogen Recent Development
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Whole Exome Sequencing Introduction
11.9.4 BGI Revenue in Whole Exome Sequencing Business (2020-2025)
11.9.5 BGI Recent Development
11.10 Novo Gene
11.10.1 Novo Gene Company Details
11.10.2 Novo Gene Business Overview
11.10.3 Novo Gene Whole Exome Sequencing Introduction
11.10.4 Novo Gene Revenue in Whole Exome Sequencing Business (2020-2025)
11.10.5 Novo Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Whole Exome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Agilent HaloPlex
Table 3. Key Players of Agilent SureSelect
Table 4. Key Players of Agilent SureSelect QXT
Table 5. Key Players of Illumina TruSeq Exome
Table 6. Key Players of Roche Nimblegen SeqCap
Table 7. Key Players of MYcroarray MYbaits
Table 8. Global Whole Exome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Whole Exome Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Whole Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Whole Exome Sequencing Market Share by Region (2020-2025)
Table 12. Global Whole Exome Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Whole Exome Sequencing Market Share by Region (2026-2031)
Table 14. Whole Exome Sequencing Market Trends
Table 15. Whole Exome Sequencing Market Drivers
Table 16. Whole Exome Sequencing Market Challenges
Table 17. Whole Exome Sequencing Market Restraints
Table 18. Global Whole Exome Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Whole Exome Sequencing Market Share by Players (2020-2025)
Table 20. Global Top Whole Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Exome Sequencing as of 2024)
Table 21. Ranking of Global Top Whole Exome Sequencing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Whole Exome Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Whole Exome Sequencing, Headquarters and Area Served
Table 24. Global Key Players of Whole Exome Sequencing, Product and Application
Table 25. Global Key Players of Whole Exome Sequencing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Whole Exome Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Whole Exome Sequencing Revenue Market Share by Type (2020-2025)
Table 29. Global Whole Exome Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Whole Exome Sequencing Revenue Market Share by Type (2026-2031)
Table 31. Global Whole Exome Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Whole Exome Sequencing Revenue Market Share by Application (2020-2025)
Table 33. Global Whole Exome Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Whole Exome Sequencing Revenue Market Share by Application (2026-2031)
Table 35. North America Whole Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Whole Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Whole Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Whole Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Whole Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Whole Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Whole Exome Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Whole Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Whole Exome Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Whole Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Whole Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Whole Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Whole Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Whole Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Whole Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 50. Illumina Company Details
Table 51. Illumina Business Overview
Table 52. Illumina Whole Exome Sequencing Product
Table 53. Illumina Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 54. Illumina Recent Development
Table 55. Thermo Fisher Company Details
Table 56. Thermo Fisher Business Overview
Table 57. Thermo Fisher Whole Exome Sequencing Product
Table 58. Thermo Fisher Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 59. Thermo Fisher Recent Development
Table 60. Roche Company Details
Table 61. Roche Business Overview
Table 62. Roche Whole Exome Sequencing Product
Table 63. Roche Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 64. Roche Recent Development
Table 65. Angilent Company Details
Table 66. Angilent Business Overview
Table 67. Angilent Whole Exome Sequencing Product
Table 68. Angilent Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 69. Angilent Recent Development
Table 70. Eurofins Company Details
Table 71. Eurofins Business Overview
Table 72. Eurofins Whole Exome Sequencing Product
Table 73. Eurofins Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 74. Eurofins Recent Development
Table 75. Sengenics Company Details
Table 76. Sengenics Business Overview
Table 77. Sengenics Whole Exome Sequencing Product
Table 78. Sengenics Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 79. Sengenics Recent Development
Table 80. Ambry Company Details
Table 81. Ambry Business Overview
Table 82. Ambry Whole Exome Sequencing Product
Table 83. Ambry Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 84. Ambry Recent Development
Table 85. Macrogen Company Details
Table 86. Macrogen Business Overview
Table 87. Macrogen Whole Exome Sequencing Product
Table 88. Macrogen Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 89. Macrogen Recent Development
Table 90. BGI Company Details
Table 91. BGI Business Overview
Table 92. BGI Whole Exome Sequencing Product
Table 93. BGI Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 94. BGI Recent Development
Table 95. Novo Gene Company Details
Table 96. Novo Gene Business Overview
Table 97. Novo Gene Whole Exome Sequencing Product
Table 98. Novo Gene Revenue in Whole Exome Sequencing Business (2020-2025) & (US$ Million)
Table 99. Novo Gene Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Whole Exome Sequencing Picture
Figure 2. Global Whole Exome Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Whole Exome Sequencing Market Share by Type: 2024 VS 2031
Figure 4. Agilent HaloPlex Features
Figure 5. Agilent SureSelect Features
Figure 6. Agilent SureSelect QXT Features
Figure 7. Illumina TruSeq Exome Features
Figure 8. Roche Nimblegen SeqCap Features
Figure 9. MYcroarray MYbaits Features
Figure 10. Global Whole Exome Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Whole Exome Sequencing Market Share by Application: 2024 VS 2031
Figure 12. Correlation Research of Normal Human Case Studies
Figure 13. Mendelian Disease and Rare Syndrome Gene Discovery Case Studies
Figure 14. The Research of Complex Diseases Case Studies
Figure 15. Mouse Exome Sequencing Case Studies
Figure 16. Whole Exome Sequencing Report Years Considered
Figure 17. Global Whole Exome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Whole Exome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Whole Exome Sequencing Market Share by Region: 2024 VS 2031
Figure 20. Global Whole Exome Sequencing Market Share by Players in 2024
Figure 21. Global Top Whole Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Exome Sequencing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Whole Exome Sequencing Revenue in 2024
Figure 23. North America Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Whole Exome Sequencing Market Share by Country (2020-2031)
Figure 25. United States Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Whole Exome Sequencing Market Share by Country (2020-2031)
Figure 29. Germany Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Whole Exome Sequencing Market Share by Region (2020-2031)
Figure 37. China Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Whole Exome Sequencing Market Share by Country (2020-2031)
Figure 45. Mexico Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Whole Exome Sequencing Market Share by Country (2020-2031)
Figure 49. Turkey Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Whole Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Illumina Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 53. Thermo Fisher Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 55. Angilent Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 56. Eurofins Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 57. Sengenics Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 58. Ambry Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 59. Macrogen Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 60. BGI Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 61. Novo Gene Revenue Growth Rate in Whole Exome Sequencing Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
